Thermus thermophilus nucleoside phosphorylases active in the synthesis of nucleoside analogues

Applied and Environmental Microbiology

Volumn 78, Issue 9, 2012, Pages 3128-3135

  Almendros, Marcos ^a,b   Berenguer, José ^a   Sinisterra, Jose Vicente ^b  

^a CSIC   (Spain)

^b Servicio de Biotransformaciones Industriales   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTICAL ULTRACENTRIFUGATION; ENCODING GENES; HOMODIMERS; IN-VITRO; KINETIC CONSTANT; NATURAL SUBSTRATES; NUCLEOBASES; NUCLEOSIDE ANALOGUES; NUCLEOSIDE PHOSPHORYLASE; OPTIMAL TEMPERATURE; PHARMACOLOGICAL ACTIVITY; PHOSPHOROLYSIS; PYRIMIDINE NUCLEOSIDES; THERMUS THERMOPHILUS;

AROMATIC COMPOUNDS; CENTRIFUGATION; CLONING; ENZYMES; ESCHERICHIA COLI; GENES; OPTIMIZATION; PHOSPHORYLATION; RATE CONSTANTS; RECOMBINANT PROTEINS;

BIOMOLECULES;

GLYCOSYLTRANSFERASE; NUCLEOSIDE; NUCLEOSIDE PHOSPHORYLASE; RECOMBINANT PROTEIN;

BACTERIUM; CLONE; DRUG; ENZYME ACTIVITY; GENE EXPRESSION; PH; PROTEIN; REACTION KINETICS; RECOMBINATION;

ARTICLE; CHEMISTRY; ENZYME SPECIFICITY; ENZYME STABILITY; ENZYMOLOGY; ESCHERICHIA COLI; GENE EXPRESSION; GENETICS; ISOLATION AND PURIFICATION; KINETICS; METABOLISM; MOLECULAR CLONING; PH; PROTEIN MULTIMERIZATION; TEMPERATURE; THERMUS THERMOPHILUS;

CLONING, MOLECULAR; ENZYME STABILITY; ESCHERICHIA COLI; GENE EXPRESSION; HYDROGEN-ION CONCENTRATION; KINETICS; NUCLEOSIDES; PENTOSYLTRANSFERASES; PROTEIN MULTIMERIZATION; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY; TEMPERATURE; THERMUS THERMOPHILUS;

ESCHERICHIA COLI; THERMUS THERMOPHILUS;

EID: 84861164801     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.07605-11     Document Type: Article

References (34)

1. Afshar S, Sawaya MR, Morrison SL. 2009. Structure of a mutant human purine nucleoside phosphorylase with the prodrug, 2-fluoro-2'-deoxyadenosine and the cytotoxic drug, 2-fluoroadenine. Protein Sci. 18: 1107-1114.
2. Almendros M, Sinisterra JV, Berenguer J. 2009. Thermus thermophilus strains active in purine nucleoside synthesis. Molecules 14:1279-1287.
3. Averhoff B, Müller V. 2010. Exploring research frontiers in microbiology: recent advances in halophilic and thermophilic extremophiles. Res. Microbiol. 161:506-514.
4. Bzowska A, Kulikowska E, Shugar D. 2000. Purine nucleoside phosphorylases: properties, functions, and clinical aspects. Pharmacol. Ther. 88: 349-425.
5. Condezo LA, Fernandez-Lucas J, Garcia-Burgos CA, Alcantara AR, Sinisterra JV. 2006. Enzymatic synthesis of modified nucleosides, p 401-423. In Patel RN (ed), Biocatalysis in the pharmaceutical and biotechnology industries. CRC Press, Inc, Boca Raton, FL.
6. Engelbrecht HL, Sadoff HL. 1969. Properties of purine nucleoside phosphorylases from spores and vegetative cells of Bacillus cereus and their modification by orthophosphate. J. Biol. Chem. 244:6228-6232.
7. Gardner R, Kornberg A. 1967. Biochemical studies of bacterial sporulation and germination. V. Purine nucleoside phosphorylase of vegetative cells and spores of Bacillus cereus. J. Biol. Chem. 242:2383-2388.
8. Hammer-Jespersen K, Buxton RS, Hansen TD. 1980. A second purine nucleoside phosphorylase in Escherichia coli K-12. II. Properties of xanthosine phosphorylase and its induction by xanthosine. Mol. Gen. Genet. 179:341-348.
9. Henne A, et al. 2004. The genome sequence of the extreme thermophile Thermus thermophilus. Nat. Biotechnol. 22:547-553.
10. Hiratsuka T, et al. 2008. An alternative menaquinone biosynthetic pathway operating in microorganisms. Science 321:1670-1673.
11. Hori N, Watanabe M, Sunagawa K, Uehara K, Mikami Y. 1991. Production of 5-methyluridine by immobilized thermostable purine nucleoside phosphorylase and pyrimidine nucleoside phosphorylase from Bacillus stearothermophilus JTS 859J. Biotechnol. 17:121-131.
12. Jenney FE, Jr, Adams MW. 2008. The impact of extremophiles on structural genomics (and vice versa). Extremophiles 12:39-50.
13. Kim C, et al. 2002. The crystal structure of anthranilate phosphoribosyltransferase from the enterobacterium Pectobacterium carotovorum. FEBS Lett. 523:239-246.
14. Koszalka GW, Vanhooke J, Short SA, Hall WW. 1988. Purification and properties of inosine-guanosine phosphorylase from Escherichia coli K-12. J. Bacteriol. 170:3493-3498.
15. Krenitsky TA, Koszalka GW, Tuttle JV. 1981. Purine nucleoside synthesis, an efficient method employing nucleoside phosphorylases. Biochemistry 20:3615-3621.
16. Krenitsky TA, et al. 1982. Pyrazolo[3,4-d]pyrimidine ribonucleosides as anticoccidials. 1. Synthesis and activity of some nucleosides of purines and 4-(alkylthio)pyrazolo[3,4-d]pyrimidines. J. Med. Chem. 25:32-35.
17. Mikhailopulo IA. 2007. Biotechnology of nucleic acid constituents: state of the art and perspectives. Curr. Org. Chem. 11:317-335.
18. Miyadera K, Emura T, Wierzba K, Yamada Y. July 2001. Cancerous metastasis inhibitors containing uracil derivatives. U.S. patent 6,255,314 B1.
19. Okuyama K, Hamamoto T, Noguchi T, Midorikawa Y. 1996. Molecular cloning and expression of the pyrimidine nucleoside phosphorylase gene from Bacillus stearothermophilus TH 6-2. Biosci. Biotechnol. Biochem. 60:1655-1659.
20. Parker WB, Allan PW, Waud WR, Hong JS, Sorscher EJ. 2011. Effect of expression of adenine phosphoribosyltransferase on the in vivo antitumor activity of prodrugs activated by Escherichia coli purine nucleoside phosphorylase. Cancer Gene Ther. 18:390-398.
21. Parker WB, et al. 1997. In vivo gene therapy of cancer with Escherichia coli purine nucleoside phosphorylase. Hum. Gene Ther. 8:1637-1644.
22. Prasad AK, Trikha S, Parmar VS. 1999. Nucleoside synthesis mediated by glycosyl transferring enzymes. Bioorg. Chem. 27:135-154.
23. Pugmire MJ, Ealick SE. 1998. The crystal structure of pyrimidine nucleoside phosphorylase in a closed conformation. Structure 6:1467-1479.
24. Pugmire MJ, Ealick SE. 2002. Structural analyses reveal two distinct families of nucleoside phosphorylases. Biochem. J. 361:1-25.
25. Schuck P. 2000. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and Lamm equation modeling. Biophys. J. 78:1606-1619.
26. Scocca JJ. 1971. Purification and substrate specificity of pyrimidine nucleoside phosphorylase from Haemophilus influenzae. J. Biol. Chem. 246: 6606-6610.
27. Swords R, Giles F. 2007. Troxacitabine in acute leukemia. Hematology 12:219-227.
28. Tahirov TH, et al. 2004. Crystal structure of purine nucleoside phosphorylase from Thermus thermophilus. J. Mol. Biol. 337:1149-1160.
29. Tai CK, et al. 2010. Enhanced efficiency of prodrug activation therapy by tumor-selective replicating retrovirus vectors armed with the Escherichia coli purine nucleoside phosphorylase gene. Cancer Gene Ther. 17:614-623.
30. Taran SA, Verevkina KN, Feofanov SA, Miroshnikov AI. 2009. Enzymatic transglycosylation of natural and modified nucleosides by immobilized thermostable nucleoside phosphorylases from Geobacillus stearothermophilus. Bioorg. Khim. 35:822-829.
31. Trelles JA, et al. 2004. Immobilized Escherichia coli BL21 as a catalyst for the synthesis of adenine and hypoxanthine nucleosides. Chem. Biodivers. 1:280-288.
32. Vieille C, Zeikus GJ. 2001. Hyperthermophilic enzymes: sources, uses, and molecular mechanisms for thermostability. Microbiol. Mol. Biol. Rev. 65:1-43.
33. Vorbrüggen H, Ruh-Pohlenz C. 2001. Handbook of nucleoside synthesis. John Wiley & Sons, Inc, New York, NY.
34. Wiltshire H, et al. 2005. Pharmacokinetic profile of ganciclovir after its oral administration and from its prodrug, valganciclovir, in solid organ transplant recipients. Clin. Pharmacokinet. 44:495-507.